• to lower the chance of severe cardiovascular (coronary heart and blood vessel) troubles in Older people with kind two diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched ideas for an experimental weight loss capsule in May but is still hoping for the slice of the marketplace with MariTide, a regular monthly injection th